Neuropsychiatric Disorders in Cushing’s Syndrome
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are crucial in the initiation and consolidation of the stress response. Patients with active Cushing’s syndrome (CS) are exposed to excessive endogenous glucocorticoid levels. In these patients, psychopathology is often being observed. The most common co-morbid disorder is major depression, but to a lesser extent mania and anxiety disorders have also been reported. A severe clinical presentation of CS often also includes depression. Reduction of glucocorticoid synthesis or action, either with metyrapone, ketoconazole, or mifepristone, rather than treatment with antidepressant drugs, is generally successful in relieving depressive symptoms, as well as other disabling symptoms. Following successful surgical treatment of hypercortisolism, both physical and psychiatric signs and symptoms improve substantially. However, it appears that patients do not completely return to their premorbid level of functioning and persistent impairment of quality of life and cognitive function has been reported despite long-term cure. At present, it is not clear whether, and to which extent, psychopathology still affects general well-being after long-term cure of CS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the high prevalence of depressive symptoms in hypercortisolaemic states, both pathological as in Cushing’s syndrome,10 as well as iatrogenic such as in long-term exogenous steroid use,11 it seems plausible that abnormal HPA function could increase the risk of subsequent depression.”
From Cortisol awakening response and subsequent depression: prospective longitudinal study (2014) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verhelst, J. A., Trainer, P. J., Howlett, T. A., Perry, L., Rees, L. H., Grossman, A. B., Wass, J. A. H., & Sesser, G. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03517.x · Cited by 308 · cited 1×
“This impressive treatment efficacy was later confirmed in another study with 53 patients with Cushing’s disease pretreated with metyrapone and 24 patients who had been given pituitary irradiation for a median duration of 27 months (12).”
ResultDorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260 · cited 2×
“Intriguingly, even after correction of hypercortisolism, atypical depressive disorder continued to be the prevailing diagnosis, whereas the frequency of suicidal ideation and panic disorder increased (15).”
BackgroundSubtle cognitive impairments in patients with long-term cure of Cushing’s disease
Tiemensma, J., Kokshoorn, N. E., Biermasz, N. R., Keijser, B.-J. S. A., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2032 · Cited by 159 · cited 1×
“Finally, patients cured of Cushing’s disease also made fewer correct substitutions (on the Letter-Digit Substitution Test) and came up with fewer correct patterns (on the Figure Fluency Test) compared with treated NFMA patients (18).”
ResultSelf-citation
Research works printed but not linked: 17
- 10.1038%2Fnrn1683 · DOI · Paper page
- 10.1210%2Fjcem-12-5-502 · DOI
- 10.1007%2FBF01420501 · DOI
- 10.1046%2Fj.1365-2265.1996.8690878.x · DOI · Paper page
- 10.1001%2Farchinte.141.2.215 · doi:10.1001/archinte.141.2.215 · Paper page
- 10.1192%2Fbjp.136.2.120 · DOI · Paper page
- 10.1192%2Fbjp.136.2.125 · DOI · Paper page
- 10.1055%2Fs-2007-1014405 · DOI · Paper page
- 10.1159%2F000029054 · DOI · Paper page
- 10.1159%2F000012396 · DOI · Paper page
- 10.1530%2FEJE-09-0098 · DOI · Paper page
- 10.1016%2F0165-1781%2886%2990096-X · DOI
- 10.1210%2Fjc.82.3.912 · doi:10.1210/jc.82.3.912 · Paper page
- 10.1210%2Fjc.2004-1375 · DOI · Paper page
- 10.1111%2Fj.1365-2265.2006.02462.x · DOI · Paper page
- 10.1111%2Fj.1365-2265.1995.tb02614.x · DOI · Paper page
- 10.1055%2Fs-2000-8144 · DOI · Paper page
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Dynamics of ACTH and Cortisol Secretion and Implications for Disease
Lightman, S. L., Birnie, M. T., & Conway-Campbell, B. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa002 · Cited by 439
James, K. A., Stromin, J. I., Steenkamp, N., & Combrinck, M. I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085950 · Cited by 364
Cortisol and depression: three questions for psychiatry
Herbert, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712000955 · Cited by 301
“Reexamining recovered Cushing’s patients in the expectation that they return to a basal, pre-morbid state is vitiated by knowledge that recovery is often incomplete and the effects of hypercortisolaemia are prolonged (Pereira et al. 2010 ; Tiemensma et al. 2010).”
BackgroundCushing's syndrome: epidemiology and developments in disease management
Feelders, R., Sharma, S., & Nieman, L. (2015) · Clinical Epidemiology · doi:10.2147/clep.s44336 · Cited by 210
“psychiatric and cognitive symptoms improve after remission, many symptoms may persist.(45,46)”
Predictors of Mortality and Long-term Outcomes in Treated Cushing's Disease: A Study of 346 Patients
Lambert, J. K., Goldberg, L., Fayngold, S., Kostadinov, J., Post, K. D., & Geer, E. B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2893 · Cited by 186
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment
van der Pas, R., Leebeek, F. W. G., Hofland, L. J., de Herder, W. W., & Feelders, R. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12094 · Cited by 162
Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up
Ntali, G., Asimakopoulou, A., Siamatras, T., Komninos, J., Vassiliadi, D., Tzanela, M., Tsagarakis, S., Grossman, A. B., Wass, J. A. H., & Karavitaki, N. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0569 · Cited by 149
Mechanisms of antidepressant resistance
El-Hage, W., Leman, S., Camus, V., & Belzung, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00146 · Cited by 111
Belzung, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.342 · Cited by 106
“…disease, a decrease in glucocorticoid synthesis or action rather than antidepressant therapy results in remission of the depressive symptoms (Pereira et al, 2010); therefore, high predictive validity of an animal model based on excessive glucocorticoids should in fact correspond to poor…”
Backgroundvan Haalen, F. M., Broersen, L. H. A., Jorgensen, J. O., Pereira, A. M., & Dekkers, O. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0556 · Cited by 103
Self-citationApproach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91
Cortisol awakening response and subsequent depression: prospective longitudinal study
Carnegie, R., Araya, R., Ben-Shlomo, Y., Glover, V., O'Connor, T. G., O'Donnell, K. J., Pearson, R., & Lewis, G. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.126250 · Cited by 73
Tabarin, A., Assié, G., Barat, P., Bonnet, F., Bonneville, J. F., Borson-Chazot, F., Bouligand, J., Boulin, A., Brue, T., Caron, P., et al. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.001 · Cited by 59
Savas, M., Vinkers, C. H., Rosmalen, J. G. M., Hartman, C. A., Wester, V. L., van den Akker, E. L. T., Iyer, A. M., McEwen, B. S., & van Rossum, E. F. C. (2020) · Neuroendocrinology · doi:10.1159/000501617 · Cited by 55
Broersen, L. H. A., Andela, C. D., Dekkers, O. M., Pereira, A. M., & Biermasz, N. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01054 · Cited by 42
Self-citationCortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease
van der Pas, R., de Bruin, C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M., de Jong, F. H., van der Lely, A. J., de Herder, W. W., et al. (2013) · Pituitary · doi:10.1007/s11102-012-0452-2 · Cited by 39
Self-citationBauduin, S. E. E. C., den Rooijen, I. L. B., Meijer, M., van der Werff, S. J. A., Keo, A., Dzyubachyk, O., Pereira, A. M., Giltay, E. J., van der Wee, N. J. A., Meijer, O. C., et al. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105334 · Cited by 9
“These persistent impairments are predominant within the domains of cognitive function and psychopathology (Andela et al., 2013; Bas-Hoogendam et al., 2015; Dorn et al., 1995; Pereira et al., 2010; Pivonello et al., 2015; Ragnarsson et al., 2012; Sonino and Fava, 2001; Tiemensma et al., 2010).”
BackgroundSelf-citation
Metadata
- Authors
- Pereira, A. M., Tiemensma, J., & Romijn, J. A.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 92
- Issue
- Suppl. 1
- Pages
- 65-70
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2030042518
- Cited by
- 145
- References
- 3
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.